ImmuCell Corporation Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ImmuCell Corporation (ICCC) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $875.88 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-30
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $875.88K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $717.86K.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $514.38K.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $272.79K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $875.88K 10-K · filed 2026-03-30 |
| 2025-09-30 | $717.86K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $514.38K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $272.79K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $365.12K 10-K · filed 2025-03-28 |
| 2024-09-30 | $433.32K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $446.49K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $510.13K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $619.85K 10-K · filed 2024-04-01 |
| 2023-09-30 | $685.68K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |